Disintegrin and venom protease inhibitor

Disintegrins and small venom proteinase inhibitors are non-enzymatic proteins found in the venom of African vipers, including the genera Bitis, Echis, and Cerastes (Calvete et al., 2007, Journal of Proteome Research). Disintegrins are small, cysteine-rich peptides that typically contain an RGD (Arg-Gly-Asp) or KTS (Lys-Thr-Ser) motif, allowing them to bind with high affinity to integrin receptors like alpha-IIb-beta-3 on platelet surfaces (UniProt, 2023). This binding inhibits platelet aggregation and disrupts the blood clotting process, contributing to the hemorrhagic effects of a snakebite (PubMed, PMID: 15590502). Small proteinase inhibitors, such as Kunitz-type inhibitors, further exacerbate these effects by inhibiting serine proteases involved in the coagulation cascade (Juarez et al., 2008). Beyond their role in envenomation, these molecules are highly valued in pharmacology as templates for anti-thrombotic drugs. For example, the development of the glycoprotein IIb/IIIa inhibitor eptifibatide was directly inspired by the structure and function of snake venom disintegrins (NCBI, PubChem). Consequently, these proteins are significant both as toxins requiring neutralization by antivenoms and as molecular scaffolds for drug design in cardiovascular and oncology research.

Other names

Snake venom disintegrinsKunitz-type protease inhibitorsSVMP-derived peptidesRGD-containing peptidesBitis disintegrinsEchis disintegrinsSmall venom proteinase inhibitors

Disintegrins act by competitively binding to integrin receptors, such as alpha-IIb-beta-3 (GPIIb/IIIa) and alpha-v-beta-3, on the surface of platelets and other cells, thereby preventing the binding of fibrinogen or other extracellular matrix proteins (PubMed, PMID: 11461235). Small proteinase inhibitors, such as Kunitz-type inhibitors, bind to the active sites of serine proteases like trypsin, chymotrypsin, or plasmin, preventing their catalytic activity in the coagulation cascade or fibrinolysis (UniProt, 2024).